代谢性帕金森病 代谢性帕金森病
Federica Invernizzi1, Lorenzo Ciocca1,2, Elena Contaldi3
1Center for Liver disease, Division of Internal Medicine and Hepatology, IRCCS Ospedale San Raffaele, Milan, Italy.
Frontiers in aging neuroscience
|October 27, 2025
概括
帕金森病 (PD) 与糖尿病等代谢问题有关. 对代谢疾病的治疗对PD有希望,表明共同的原因和新的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 代谢障碍 代谢障碍 代谢障碍
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 涉及多巴胺能神经元损失.
- 越来越多的证据将PD与代谢功能障碍联系起来,如2型糖尿病,肥胖和代谢综合征.
- 共享的致病机制包括胰岛素抵抗,炎症,线粒体功能障碍和肠道微生物群的变化.
研究的目的:
- 探索代谢障碍与帕金森病之间的联系.
- 调查潜在的共同病因因素和治疗策略.
- 要突出用于两种条件的药物的交叉疗效.
主要方法:
- 对PD和代谢障碍的临床前和临床研究的综述.
- 分析共享的细胞损伤模式 (线粒体功能障碍,氧化应激等). ) 的情况.
- 检查药物重用潜力 (例如,甲福明,隐仿真剂,克里丁).
主要成果:
- 代谢功能障碍与PD共享细胞损伤途径.
- 抗糖尿病药物 (甲福明,英克雷丁模仿剂) 在PD中表现出神经保护作用.
- 抗帕金森症药物 (布罗莫克里普丁) 可以改善糖尿病的血糖控制.
结论:
- 代谢障碍和PD之间的共享致病性被假设.
- 了解这些联系可以导致PD的新型预防和治疗策略.
- 生活方式,饮食修改和重新设计的药物提供了潜在的疾病修改方法.
相关概念视频
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Parkinson's Disease: Treatment
970
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
970
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Overview of Metabolism
37.6K
Living cells constantly carry out various chemical reactions which are necessary for their proper functioning. These reactions are interlinked to one another via multiple pathways. The collection of these chemical reactions is known as metabolism.
Plant Metabolism
Sunlight, the primary source of energy in plants, is first absorbed by the chlorophyll pigments present in their leaves. Plants then use this energy to carry out photosynthesis, where water is oxidized into oxygen and carbon dioxide...
Plant Metabolism
Sunlight, the primary source of energy in plants, is first absorbed by the chlorophyll pigments present in their leaves. Plants then use this energy to carry out photosynthesis, where water is oxidized into oxygen and carbon dioxide...
37.6K
Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K


